alexa Survivin Gene as a Potential Marker in Premalignant and Malignant Lesions of Oral Cavity | OMICS International| Abstract
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Otolaryngol (Sunnyvale) 2018, Vol 8(1): 341
  • DOI: 10.4172/2161-119X.1000341

Survivin Gene as a Potential Marker in Premalignant and Malignant Lesions of Oral Cavity

Lingamdenne Paul Emerson1* and Pallipamu Prakash Babu2
1Department of ENT, Christian Medical College, , Vellore, Tamil Nadu, India
2Department of Research and Administration, Arogyavaram Medical centre, , Madanapalle, Andhra Pradesh, India
*Corresponding Author : Lingamdenne Paul Emerson M.S., Department of ENT, Christian Medical College, Vellore, Tamil Nadu, India, Tel: 9894500172, Email: [email protected]

Received Date: Jan 25, 2018 / Accepted Date: Feb 05, 2018 / Published Date: Feb 12, 2018


In a developing country where most of the people live in rural areas, Oral cancer management is a challenge with most of the cases presenting late. Carcinogenesis is a multistage process involving the activation of oncogenes and the inactivation of tumour suppressor genes. Biomarkers are important in establishing an accurate diagnosis and also can provide prognostic data. Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and blocks cell death, is highly expressed in most cancers and is associated with a poor clinical outcome. Survivin has consistently been identified by molecular profiling analysis to be associated with high tumour grade cancers, disease survival and recurrence. Polymorphisms in the survivin gene are emerging as powerful tools to study the biology of the disease and have the potential to be used in disease prognosis and diagnosis. The survivin gene polymorphisms have also been reported to influence tumour aggressiveness as well as survival of cancer patients. The differential expression of survivin in cancer cells compared to normal tissues and its role as a nodal protein in a number of cellular pathways make it a high target for different therapeutics. This review focuses on the literature on survivin, its role in cancerous and pre-cancerous lesions of oral cavity. It also gives a snapshot of its use in diagnosis, management and therapeutic management.

Keywords: Oral squamous cell carcinoma; Premalignant lesions; Biomarkers; Survivin; Prognostic and diagnostic indicators

Citation: Emerson LP, Babu PP (2018) Survivin Gene as a Potential Marker in Premalignant and Malignant Lesions of Oral Cavity. Otolaryngol (Sunnyvale) 8: 341. Doi: 10.4172/2161-119X.1000341

Copyright: ©2018 Emerson LP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1961
  • [From(publication date): 0-2018 - Nov 30, 2020]
  • Breakdown by view type
  • HTML page views: 1818
  • PDF downloads: 143